{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:13:28Z","timestamp":1771845208875,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,24]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Vaping of cannabinoid-based products and informal acquisition of vaping products were associated with the outbreak of E-cigarette or vaping associated lung injury (EVALI) in the USA. Current prevalence of cannabinoid-based vaping within the UK is not known and literature regarding the acquisition of vaping products is limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To estimate the prevalence of nicotine-based, nicotine-free and cannabinoid-based product vaping within the UK and to determine where vaping products are acquired.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and methods<\/jats:title><jats:p>A voluntary online survey of individuals aged 16 and over within the UK was conducted using a convenience sample. Data were collected on respondent demographics, smoking\/vaping history and acquisition of e-liquids\/products.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2478 responses were included. Median age 45\u2009years (interquartile range 35\u201357). Prevalence of current vaping of nicotine-based e-liquids, nicotine-free e-liquids and cannabinoid-based products was 14.4%, 11.2% and 5.49%, respectively. Current nicotine-based and nicotine-free vaping was most prevalent in 25\u201334\u2009years olds (22.4% and 19.2% of respondents). Current cannabinoid-based vaping was most prevalent in 16\u201324\u2009years olds. The most common \u2018ever\u2019 used cannabinoid-based products were cannabidiol oil\/cannabigerol oil and cannabis leaves (4.8%). Specialist vaping stores were the most common source of \u2018ever\u2019 acquisition for all products. 36.8% and 40.5% of respondents who had ever vaped nicotine-based and nicotine-free e-liquids reported prior acquisition from informal sources.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This survey reported a higher prevalence of current cannabinoid-based vaping within the UK (5.5%) than previously reported in the USA (2.0%). In addition to the informal acquisition of vaping products as demonstrated within the survey, these results highlight potential underestimation of the risk of EVALI within the UK.<\/jats:p><\/jats:sec>","DOI":"10.1093\/qjmed\/hcac220","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T14:17:57Z","timestamp":1662473877000},"page":"99-106","source":"Crossref","is-referenced-by-count":3,"title":["The unseen cloud: a survey of vaping practices and the acquisition of vaping products within the UK"],"prefix":"10.1093","volume":"116","author":[{"given":"L J","family":"Sund","sequence":"first","affiliation":[{"name":"Emergency Medicine, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s Health Partners From the , London, UK"},{"name":"Clinical Toxicology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s Health Partners , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D M","family":"Wood","sequence":"additional","affiliation":[{"name":"Clinical Toxicology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s Health Partners , London, UK"},{"name":"Faculty of Life Sciences and Medicine, King\u2019s College London , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R H","family":"Archer","sequence":"additional","affiliation":[{"name":"Clinical Toxicology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s Health Partners , London, UK"},{"name":"Faculty of Life Sciences and Medicine, King\u2019s College London , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M S","family":"Blundell","sequence":"additional","affiliation":[{"name":"Emergency Medicine, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s Health Partners From the , London, UK"},{"name":"Clinical Toxicology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s Health Partners , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P I","family":"Dargan","sequence":"additional","affiliation":[{"name":"Clinical Toxicology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s Health Partners , London, UK"},{"name":"Faculty of Life Sciences and Medicine, King\u2019s College London , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"2023022420323235700_","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(19)32277-9","article-title":"E-cigarettes: time to realign our approach?","volume":"394","author":"The Lancet","year":"2019","journal-title":"Lancet"},{"key":"2023022420323235700_","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2213-2600(19)30468-0","article-title":"A public health emergency among young people","volume":"8","author":"Bush","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2023022420323235700_","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(20)30113-6","article-title":"The need for an evidence-based and rational debate on e-cigarettes","volume":"395","author":"Shahab","year":"2020","journal-title":"Lancet"},{"key":"2023022420323235700_","doi-asserted-by":"crossref","first-page":"107838","DOI":"10.1016\/j.pharmthera.2021.107838","article-title":"Toxicology of flavoring- and cannabis-containing e-liquids used in electronic delivery systems","volume":"224","author":"Stefaniak","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2023022420323235700_","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1916433","article-title":"Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI","volume":"382","author":"Blount","year":"2020","journal-title":"N Engl J Med"},{"key":"2023022420323235700_","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.toxrep.2020.09.010","article-title":"E-cigarette or vaping induced lung injury: a case series and literature review","volume":"7","author":"Doukas","year":"2020","journal-title":"Toxicol Rep"},{"key":"2023022420323235700_","volume-title":"Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"2023022420323235700_","first-page":"bcr-2018-224350","article-title":"Respiratory failure caused by lipoid pneumonia from vaping e-cigarettes","volume":"2018","author":"Viswam","year":"2018","journal-title":"BMJ Case Rep"},{"key":"2023022420323235700_","first-page":"1114","article-title":"Life-threatening hypersensitivity pneumonitis secondary to e-cigarettes","volume":"105","author":"Nair","year":"2020","journal-title":"Arch Dis Child"},{"key":"2023022420323235700_","first-page":"e237338","article-title":"Lung injury from e-cigarette use: a foul and pestilent congregation of vapours","volume":"13","author":"Chapman","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2023022420323235700_","first-page":"177","article-title":"Three patients with acute pulmonary damage following the use of e-cigarettes\u2014a case series","volume":"117","author":"Suhling","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"2023022420323235700_","first-page":"564","article-title":"E-cigarette-induced lung disease: from acute to chronic","volume":"396","author":"Poschenrieder","year":"2020","journal-title":"Lancet"},{"key":"2023022420323235700_","first-page":"2000077","article-title":"Fatal e-cigarette or vaping associated lung injury (EVALI): a first case report in Europe","volume":"56","author":"Marli\u00e8re","year":"2020","journal-title":"Eur Respir J"},{"key":"2023022420323235700_","first-page":"e65","article-title":"A cancer that went up in smoke: pulmonary reaction to e-cigarettes imitating metastatic cancer","volume":"149","author":"Ring Madsen","year":"2016","journal-title":"Chest"},{"key":"2023022420323235700_","first-page":"706","article-title":"Vaping-associated lung injury","volume":"75","author":"O'Carroll","year":"2020","journal-title":"Thorax"},{"key":"2023022420323235700_","first-page":"1902076","article-title":"An imported case of e-cigarette or vaping associated lung injury in Barcelona","volume":"55","author":"Casanova","year":"2020","journal-title":"Eur Respir J"},{"key":"2023022420323235700_","first-page":"1026","article-title":"E-pipe use leading to lipoid pneumonia in Europe","volume":"75","author":"Kessler","year":"2020","journal-title":"Thorax"},{"key":"2023022420323235700_","first-page":"9","article-title":"A cloud on the horizon-a survey into the use of electronic vaping devices for recreational drug and new psychoactive substance (NPS) administration","volume":"111","author":"Blundell","year":"2018","journal-title":"QJM"},{"key":"2023022420323235700_","first-page":"e240700","article-title":"Case of e-cigarette or vaping product use-associated lung injury (EVALI) in London, UK","volume":"14","author":"Evans","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2023022420323235700_","first-page":"2908","article-title":"Drug-related deaths associated with vaping product use in the United Kingdom","volume":"116","author":"Roberts","year":"2021","journal-title":"Addiction"},{"key":"2023022420323235700_","volume-title":"Smoking in England: E Cigarettes Latest Trends","author":"Kock","year":"2022"},{"key":"2023022420323235700_","author":"Action on Smoking and Health (ASH)","year":"2021"},{"key":"2023022420323235700_","author":"Office for National Statistics","year":"2021","edition":"2020 edn"},{"key":"2023022420323235700_","first-page":"4111","article-title":"The prevalence of vaping and smoking as modes of delivery for nicotine and cannabis among youth in Canada, England and the United States","volume":"16","author":"Fataar","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2023022420323235700_","first-page":"107052","article-title":"Cannabis vaping among adults in the United States: prevalence, trends, and association with high-risk behaviors and adverse respiratory conditions","volume":"159","author":"Boakye","year":"2022","journal-title":"Prev Med"},{"key":"2023022420323235700_","volume-title":"Vaping and Cannabis Trends among Young Adults (19-22)","author":"National Institute on Drug Abuse","year":"2020"},{"key":"2023022420323235700_","volume-title":"Vaping in England: An Evidence Update Including Mental Health and Pregnancy, March 2020: A Report Commissioned by Public Health England","author":"McNeill","year":"2020"},{"key":"2023022420323235700_","author":"Office for National Statistics","year":"2021"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcac220\/45946958\/hcac220.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/116\/2\/99\/49331427\/hcac220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/116\/2\/99\/49331427\/hcac220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T07:21:57Z","timestamp":1727940117000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/116\/2\/99\/6692724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,9,6]]},"published-print":{"date-parts":[[2023,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcac220","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,9,6]]}}}